AlphAIalphai — Financial news for AI agents
fool.comAUG 203 min read$KE

Kimball Electronics (KE) Q4 2026 Earnings Call Transcript

Kimball Electronics (KE) reported Q4 2026 net sales of $371.6M, down 2% YoY but up 5% sequentially. Fiscal 2026 revenue was $1.431B, with medical segment growth of 11%. Adjusted operating income was $18.1M (4.9% of sales). Guidance for 2027 projects revenue of $1.535B-$1.560B, with medical sales expected to grow significantly due to the Helvoet acquisition.

Original reporting
fool.com
Published Aug 20, 2026, 12:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 1:07 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Kimball Electronics (KE) Q4 2026 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$KEBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest upside, but segmental weaknesses and integration risks temper enthusiasm.

02

Market read

Earnings and guidance are material for KE and its sector, offering a trading opportunity.

03

What to watch

Potential tax rate normalization and integration risks of Helvoet acquisition could affect near-term earnings.

Relevance 9/10Novelty 9/10Timing: post-earnings release

Background

Kimball Electronics (KE) reported its Q4 2026 results and FY 2027 outlook, highlighting segment performance, debt reduction, and a share repurchase program.

Company-level read

Ticker impact

$KEBullishHigh confidence
Context

Q4 2026 earnings released with net sales $371.6M, FY revenue $1.431B and FY 2027 guidance up to $1.560B.

Expected impact

Potential short-term price rally on guidance beat and improved balance sheet.

Evidence & confidence

Guidance above consensus and strong cash flow are likely to attract buyers, while debt reduction and repurchase program support valuation.

Market effects

Sector

Medical vertical growth may boost EMS sector peers; automotive weakness signals caution for EV component suppliers.

Regional

Improved North American debt metrics could favor regional industrial stocks.

Global

Guidance lift may influence broader electronics manufacturing sentiment.

Counterpoint

What could challenge this read

Guidance may be overly optimistic given automotive and industrial headwinds; investors could wait for Q1 data.

Key entities

  • Company
    Kimball Electronics

    US-listed electronics manufacturing services provider.

  • Acquired Company
    Helvoet Polymer Technologies

    Acquired polymer tech firm contributing to medical segment growth.

Read at source← All news

Related articles

AUG 31
$KEMed

Should You Buy Kimball Electronics Stock After Lackluster Q4 Results?

Kimball Electronics (KE) reported Q4 fiscal 2026 earnings of -$0.01 per share, missing estimates, with revenue down 2.3% YoY. Medical revenues grew 1%, while Automotive and Industrial declined. Despite the weak quarter, management expects fiscal 2027 revenue growth of 7-9%, driven by Medical market expansion and recent acquisitions. KE stock has underperformed peers over the past year.

tradingview.com2 min
AUG 13
$KEMedAI 8/10

Kimball Electronics Reports Q4 Results, Issues FY2027 Guidance Highlighted by Organic Growth and Helvoet Acquisition · EMSNow

Kimball Electronics (Nasdaq: KE) reported Q4 FY2026 ended June 30, 2026 net sales of $371.6M, up 5% sequentially but down 2% YoY. Operating income was $29.1M (7.8% margin). Diluted EPS was $0.35. Cash from operations was $42.4M; debt fell to $116.6M. FY2027 guidance: net sales $1.535–$1.560B, incl. ~$60M from Helvoet, and adjusted op margin 4.4%–4.7%.

emsnow.com4 min
AUG 12
$KEHighAI 9/10

Kimball Electronics, Inc. (KE): Results of Operations and Financial Condition

Kimball Electronics, Inc. (KE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 KIMBALL ELECTRONICS REPORTS Q4 RESULTS; COMPANY PROVIDES GUIDANCE FOR FISCAL 2027 HIGHLIGHTED BY ORGANIC SALES GROWTH AND ACCRETIVE IMPACT OF THE HELVOET ACQUISITION JASPER, Ind., August 12, 2026 -- (BUSINESS WIRE) -- Kimball Electronics, Inc. (Nasdaq: KE) today anno

SEC EDGAR 8-K6 min
JUL 1
$KEMedAI 8/10

Kimball Electronics (Nasdaq: KE) said it acquired Helvoet Polymer Technologies B.V., a Europe/India medical CDMO

Kimball Electronics (Nasdaq: KE) said it acquired Helvoet Polymer Technologies B.V., a Europe/India medical CDMO for microfluidics, diagnostics, and drug delivery, for €90m (~$103m) excluding adjustments. The deal is ~9x Helvoet 2026E adjusted EBITDA, expected accretive to fiscal 2027 adjusted earnings and to grow Kimball’s medical sales in the low double digits. Helvoet 2025 revenue was ~$56m.

stockhouse.com6 min